207 related articles for article (PubMed ID: 29667764)
1. RRM2 promotes the progression of human glioblastoma.
Li C; Zheng J; Chen S; Huang B; Li G; Feng Z; Wang J; Xu S
J Cell Physiol; 2018 Oct; 233(10):6759-6767. PubMed ID: 29667764
[TBL] [Abstract][Full Text] [Related]
2. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
3. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase
small subunit M2].
Yan D; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
5. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma.
Yang M; Yao P; Lang X; Li X; Zhang D
Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
Xu H; Hu Y; Qiu W
Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
[TBL] [Abstract][Full Text] [Related]
7. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
Kang W; Tong JH; Chan AW; Zhao J; Wang S; Dong Y; Sin FM; Yeung S; Cheng AS; Yu J; To K
Oncol Rep; 2014 Jun; 31(6):2579-86. PubMed ID: 24756820
[TBL] [Abstract][Full Text] [Related]
8. Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy.
Li J; Pang J; Liu Y; Zhang J; Zhang C; Shen G; Song L
Oncol Rep; 2018 Jul; 40(1):355-360. PubMed ID: 29749541
[TBL] [Abstract][Full Text] [Related]
9. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
Peng G; Liao Y; Shen C
Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
Das B; Jain N; Mallick B
Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP3 regulates the expression of RRM2 and promotes the progression of rheumatoid arthritis via RRM2/Akt/MMP-9 pathway.
Ban Z; Li Z; Xing S; Ye Y
PLoS One; 2024; 19(5):e0303593. PubMed ID: 38820515
[TBL] [Abstract][Full Text] [Related]
12. RRM2 is a potential prognostic biomarker with functional significance in glioma.
Sun H; Yang B; Zhang H; Song J; Zhang Y; Xing J; Yang Z; Wei C; Xu T; Yu Z; Xu Z; Hou M; Ji M; Zhang Y
Int J Biol Sci; 2019; 15(3):533-543. PubMed ID: 30745840
[TBL] [Abstract][Full Text] [Related]
13. Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
Jia WQ; Wang ZT; Zou MM; Lin JH; Li YH; Zhang L; Xu RX
Cell Physiol Biochem; 2018; 47(5):1871-1882. PubMed ID: 29961065
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
Zhao H; Zheng GH; Li GC; Xin L; Wang YS; Chen Y; Zheng XM
J Cell Physiol; 2019 Dec; 234(12):23349-23359. PubMed ID: 31169309
[TBL] [Abstract][Full Text] [Related]
15. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
[TBL] [Abstract][Full Text] [Related]
16. Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β‑catenin signaling pathway.
Liu X; Peng J; Zhou Y; Xie B; Wang J
Mol Med Rep; 2019 Sep; 20(3):2159-2166. PubMed ID: 31322175
[TBL] [Abstract][Full Text] [Related]
17. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.
Fang Z; Gong C; Liu H; Zhang X; Mei L; Song M; Qiu L; Luo S; Zhu Z; Zhang R; Gu H; Chen X
Biochem Biophys Res Commun; 2015 Aug; 464(2):407-15. PubMed ID: 26093293
[TBL] [Abstract][Full Text] [Related]
18. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
Zhang M; Wang J; Yao R; Wang L
Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.
Han P; Lin ZR; Xu LH; Zhong Q; Zhu XF; Liang FY; Cai Q; Huang XM; Zeng MS
Mol Med Rep; 2015 Jul; 12(1):401-9. PubMed ID: 25695839
[TBL] [Abstract][Full Text] [Related]
20. CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma.
Chen L; Wang L; Qin J; Wei DS
Life Sci; 2020 Dec; 262():118477. PubMed ID: 32971103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
